HU163632B - - Google Patents

Info

Publication number
HU163632B
HU163632B HUSU000621A HU163632B HU 163632 B HU163632 B HU 163632B HU SU000621 A HUSU000621 A HU SU000621A HU 163632 B HU163632 B HU 163632B
Authority
HU
Hungary
Application number
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4149870A external-priority patent/JPS499474B1/ja
Priority claimed from JP4149970A external-priority patent/JPS4911238B1/ja
Application filed filed Critical
Publication of HU163632B publication Critical patent/HU163632B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/28—Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/30—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings
    • C07D243/32—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings containing a phthalimide or hydrogenated phthalimide ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUSU000621 1970-05-14 1971-05-13 HU163632B (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4149870A JPS499474B1 (cg-RX-API-DMAC10.html) 1970-05-14 1970-05-14
JP4149970A JPS4911238B1 (cg-RX-API-DMAC10.html) 1970-05-14 1970-05-14

Publications (1)

Publication Number Publication Date
HU163632B true HU163632B (cg-RX-API-DMAC10.html) 1973-09-27

Family

ID=26381128

Family Applications (1)

Application Number Title Priority Date Filing Date
HUSU000621 HU163632B (cg-RX-API-DMAC10.html) 1970-05-14 1971-05-13

Country Status (3)

Country Link
AT (1) AT308122B (cg-RX-API-DMAC10.html)
CH (1) CH579060A5 (cg-RX-API-DMAC10.html)
HU (1) HU163632B (cg-RX-API-DMAC10.html)

Also Published As

Publication number Publication date
CH579060A5 (en) 1976-08-31
AT308122B (de) 1973-06-25

Similar Documents

Publication Publication Date Title
FR2086319B1 (cg-RX-API-DMAC10.html)
HU166109B (cg-RX-API-DMAC10.html)
FR2123091A1 (cg-RX-API-DMAC10.html)
FR2080362A5 (cg-RX-API-DMAC10.html)
FR2086317A1 (cg-RX-API-DMAC10.html)
HU164870B (cg-RX-API-DMAC10.html)
FR2123038B1 (cg-RX-API-DMAC10.html)
FR2076118B3 (cg-RX-API-DMAC10.html)
FR2086311B1 (cg-RX-API-DMAC10.html)
FR2082631A5 (cg-RX-API-DMAC10.html)
JPS4741238B1 (cg-RX-API-DMAC10.html)
FR2075102A5 (cg-RX-API-DMAC10.html)
FR2092043B1 (cg-RX-API-DMAC10.html)
JPS4816040B1 (cg-RX-API-DMAC10.html)
FR2084831A5 (cg-RX-API-DMAC10.html)
FR2123048B1 (cg-RX-API-DMAC10.html)
FR2092235A5 (cg-RX-API-DMAC10.html)
FR2086306A1 (cg-RX-API-DMAC10.html)
FR2082641A5 (cg-RX-API-DMAC10.html)
FR2086266B1 (cg-RX-API-DMAC10.html)
FR2092116A1 (cg-RX-API-DMAC10.html)
FR2123037B1 (cg-RX-API-DMAC10.html)
DK134802C (cg-RX-API-DMAC10.html)
FR2084843A5 (cg-RX-API-DMAC10.html)
JPS4721717Y1 (cg-RX-API-DMAC10.html)